Ariad Pharmaceuticals Inc. (ARIA) was a big mover last session, as the company saw its shares rise by over 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $6.46 to $7.26 in the past one-month time frame.
This biotechnology company has seen one positive revision and one negative estimate revision in the past one month and its Zacks Consensus Estimate moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if the recent move higher can last.
Ariad Pharmaceuticals currently has a Zacks Rank #2 (Buy) while its Earnings ESP is negative.
Some better-ranked stocks in the same industry include DepoMed Inc. (DEPO), Lannett Company, Inc. (LCI) and Grifols, S.A. (GRFS). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ARIAD PHARMACEUTICALS INC (ARIA): Free Stock Analysis Report
DEPOMED INC (DEPO): Free Stock Analysis Report
LANNETT COMP (LCI): Free Stock Analysis Report
GRIFOLS SA ADS (GRFS): Free Stock Analysis Report
Zacks Investment Research